Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Thouvenot

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
The Lancet Regional Health. Europe|November 25, 2022
Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort studySarah Wilson, Floriane Calocer, Fabien Rollot, et al.
JAMA Network Open|June 23, 2023
Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple SclerosisEdouard Januel, David Hajage, Pierre Labauge, et al.
Journal of Neuroinflammation|July 4, 2019
Evaluation of treatment response in adults with relapsing MOG-Ab-associated diseaseAlvaro Cobo-Calvo, María Sepúlveda, Fabien Rollot, et al.
Frontiers in Immunology|January 23, 2025
Blood immunophenotyping of multiple sclerosis patients at diagnosis identifies a classical monocyte subset associated to disease evolutionStéphane Rodriguez, Laura Couloume, Juliette Ferrant, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 16, 2023
Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS studyMikael Cohen, Océane Thomel-Rocchi, Aksel Siva, et al.
Brain : a Journal of Neurology|March 3, 2023
The radiologically isolated syndrome: revised diagnostic criteriaChristine Lebrun-Frénay, Darin T Okuda, Aksel Siva, et al.
Annals of Neurology|September 22, 2020
Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseAlvaro Cobo-Calvo, Anne Ruiz, Fabien Rollot, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 22, 2024
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022Lina Jeantin, Edouard Januel, Pierre Labauge, et al.
Annals of Clinical and Translational Neurology|July 9, 2021
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and FranceMaria Pia Sormani, Marco Salvetti, Pierre Labauge, et al.
JAMA Neurology|February 12, 2024
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple SclerosisNail Benallegue, Fabien Rollot, Sandrine Wiertlewski, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
The Lancet Regional Health. Europe|November 25, 2022
Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort studySarah Wilson, Floriane Calocer, Fabien Rollot, et al.
JAMA Network Open|June 23, 2023
Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple SclerosisEdouard Januel, David Hajage, Pierre Labauge, et al.
Journal of Neuroinflammation|July 4, 2019
Evaluation of treatment response in adults with relapsing MOG-Ab-associated diseaseAlvaro Cobo-Calvo, María Sepúlveda, Fabien Rollot, et al.
Frontiers in Immunology|January 23, 2025
Blood immunophenotyping of multiple sclerosis patients at diagnosis identifies a classical monocyte subset associated to disease evolutionStéphane Rodriguez, Laura Couloume, Juliette Ferrant, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 16, 2023
Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS studyMikael Cohen, Océane Thomel-Rocchi, Aksel Siva, et al.
Brain : a Journal of Neurology|March 3, 2023
The radiologically isolated syndrome: revised diagnostic criteriaChristine Lebrun-Frénay, Darin T Okuda, Aksel Siva, et al.
Annals of Neurology|September 22, 2020
Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseAlvaro Cobo-Calvo, Anne Ruiz, Fabien Rollot, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 22, 2024
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022Lina Jeantin, Edouard Januel, Pierre Labauge, et al.
Annals of Clinical and Translational Neurology|July 9, 2021
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and FranceMaria Pia Sormani, Marco Salvetti, Pierre Labauge, et al.
JAMA Neurology|February 12, 2024
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple SclerosisNail Benallegue, Fabien Rollot, Sandrine Wiertlewski, et al.
Pageof 15